Standard Biotools (LAB) Change in Receivables (2016 - 2025)
Historic Change in Receivables for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $5.8 million.
- Standard Biotools' Change in Receivables rose 11145.99% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of -$9.0 million for FY2024, which is 39979.94% down from last year.
- Standard Biotools' Change in Receivables amounted to $5.8 million in Q3 2025, which was up 11145.99% from $276000.0 recorded in Q2 2025.
- In the past 5 years, Standard Biotools' Change in Receivables registered a high of $6.2 million during Q3 2022, and its lowest value of -$9.8 million during Q1 2021.
- In the last 5 years, Standard Biotools' Change in Receivables had a median value of $276000.0 in 2025 and averaged -$298789.5.
- In the last 5 years, Standard Biotools' Change in Receivables plummeted by 112830.19% in 2022 and then skyrocketed by 601333.33% in 2023.
- Over the past 5 years, Standard Biotools' Change in Receivables (Quarter) stood at $4.7 million in 2021, then plummeted by 98.73% to $60000.0 in 2022, then soared by 6013.33% to $3.7 million in 2023, then plummeted by 282.52% to -$6.7 million in 2024, then skyrocketed by 186.54% to $5.8 million in 2025.
- Its Change in Receivables stands at $5.8 million for Q3 2025, versus $276000.0 for Q2 2025 and $2.0 million for Q1 2025.